AIkido Pharma Inc(NASDAQ:AIKI) 
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC...
Website: http://www.aikidopharma.com
Full Time Employees: 4 (May 2021)
CEO: Anthony C. Hayes
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-07-22
P
O 1.85
H 1.87
L 1.84
C 1.86
V 9,110
10EMA 1.86
20EMA 1.86
60EMA 1.86
120EMA 1.86
250EMA 1.86